How Differences in the Composition of Microorganisms in the Soil Affect the Microorganisms in the Human Gut, Through the Vegetables That Grow in it: a Process Pilot Study With Healthy Participants

ConditionPilot Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorLeiden University Medical Center

About this trial

There are two objectives for this clinical trial. The first is to test whether, with the current logistics and study setup it is possible to perform the study well and see where there might be bottlenecks we couldn't predict. The second objective is to investigate the relation between the composition of the microorganisms in the soil, the crops that grow in that soil, and the human gut. During the study participants will drink three vegetable smoothies a day, for two periods of one week. The only difference between the two periods is whether the vegetables come from a farm with a low diversity of microorganisms in the soil or a high diversity. Participants will be asked to give blood samples and turn in fecal samples before and after each period.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 to 70 years

Written informed consent

Inhabitant of Leiden

Disqualifiers

Any documented causes of chronic disease

Suspicion of or present excessive alcohol use defined as >2 units/day (>14/week)

Recent use (<3 months) of antibiotics

Any known food allergy or restriction, or following a vegan/vegetarian diet

Trial design

Design model

Crossover

Treatments tested in this trial

  • Low diversity vegetable smoothie

    Other intervention

    Vegetable smoothie prepared with crops grown in low-microbial diversity soil

  • High diversity vegetable smoothie

    Other intervention

    Vegetable smoothie prepared with crops grown in high-microbial diversity soil

Treatment groups

10 Participants
are divided into 2 treatment groups
Group A: Crops derived from Low followed by High diversity soilActive comparator 2 interventions
Group B: Crops derived from High followed by Low diversity soilActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Feasibility of logistics of the study protocol: Deliveries

The percentage of successful deliveries to the participants in the pre-agreed time window.

Time frame
From start enrollment to the end of treatment at 4 weeks
2

Feasibility of logistics of the study protocol: Preparation of the intervention product

Using the Daily diary (Castor questionnaire), successful preparation of the intervention product is assessed.

Time frame
From the start of the treatment period until the end at 4 weeks
3

Feasibility of logistics of the study protocol: Recruitment rate

Number of recruited participants per month until the start of the study.

Time frame
From the start of recruitment until the start of the study
4

Tracing back life microorganisms from the smoothie in stool samples

Life bacteria present in the smoothies will be cultured and sequenced to then compare to feces samples of participants

Time frame
Day 1, Day 7, Day 22, and Day 28

Secondary outcomes

1

Participant compliance to the study protocol

Compliance with the protocol will be assessed through the daily lifestyle diary (in the form of a Castor questionnaire). Which will capture the number of consumed smoothies (≥95.2%) and number of consumed smoothies at the correct time window (≥80%). As well whether the duration and time of exercise (≥80%), duration and time of nighttime sleeping period (≥80%), timing and content of main meals (≥80%) between the two periods are comparable. For each of the parameters the compliance threshold is indicated above. Based on these parameters we will get a percentage of participants that were compliant.

Time frame
From start enrolment until the end of treatment at the end of 4 weeks
2

Shifts in gut microbiome composition

Metagenomics will be performed on feces samples from participants to get an compositional view of the gut microbiome. Samples will be taken at baseline, Day 8, Day 21, and Day 29

Time frame
Baseline, Day 8, Day 21, and Day 29
3

Sample completeness

percentage of complete sampling sets

Time frame
From start of treatment to the end of treatment at 4 weeks
4

Asses willingness of participants to create their own intervention product

Using the Daily diary (Castor questionnaire), the participants are required to fill in their opinion on creating their own intervention product on a daily basis. This is measured on a 10 point scale, with 1 being equal to never wanting to do it again and 10 being equal to enjoying it. There is also an optional open question where participants can justify their answer.

Time frame
From start treatment to end of treatment at 4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Leiden University Medical Center

Lead sponsor

Maastricht University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: